Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novabay Pharmaceuticals (NY: NBY ) 2.000 -0.020 (-0.99%) Official Closing Price Updated: 8:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Novabay Pharmaceuticals < Previous 1 2 3 4 5 6 7 Next > NovaBay Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 04, 2022 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Holds Special Meeting of Stockholders December 21, 2021 From NovaBay Pharmaceuticals, Inc. Via Business Wire DERMAdoctor’s Calm Cool + Corrected Eczema Balm Receives National Eczema Association Seal of Acceptance December 13, 2021 From NovaBay Pharmaceuticals, Inc. Via Business Wire Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge May 01, 2021 Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... Via Benzinga Exposures Product Safety NovaBay Pharmaceuticals CEO Issues Letter to Stockholders November 18, 2021 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Reports Third Quarter 2021 Financial Results November 11, 2021 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Closes DERMAdoctor Acquisition November 08, 2021 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Closes $15.0 Million Private Placement November 03, 2021 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Announces Pricing of $15.0 Million Private Placement November 01, 2021 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Earnings Perspective: Return On Capital Employed October 01, 2021 Benzinga Pro data, NovaBay Pharmaceuticals (AMEX:NBY) reported Q2 sales of $2.13 million. Earnings fell to a loss of $1.86 million, resulting in a 22.3% decrease from last... Via Benzinga NovaBay Pharmaceuticals to Hold Conference Call and Webcast With Slide Presentation Today to Discuss Acquisition of DERMAdoctor September 29, 2021 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Acquires Skincare-Focused Firm For $15M September 28, 2021 NovaBay Pharmaceuticals Inc (NYSE: NBY) has agreed to acquire DERMAdoctor LLC, a privately-held company that commercializes dermatologist-developed skincare... Via Benzinga NovaBay Pharmaceuticals Signs Agreement to Acquire DERMAdoctor September 28, 2021 From NovaBay® Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals to Present at the H.C. Wainwright 23nd Annual Global Investment Conference September 08, 2021 From NovaBay® Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals to Distribute Zocular® Dry Eye Products August 19, 2021 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Reports Second Quarter 2021 Financial Results August 12, 2021 From NovaBay Pharmaceuticals, Inc. Via Business Wire Earnings Scheduled For August 12, 2021 August 12, 2021 Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS... Via Benzinga NovaBay Pharmaceuticals to Hold Second Quarter 2021 Conference Call on August 12 August 05, 2021 From NovaBay Pharmaceuticals, Inc. Via Business Wire 21 Stocks Moving in Monday's Pre-Market Session August 02, 2021 Gainers Exicure, Inc. (NASDAQ: XCUR) shares rose 41.5% to $1.91 in pre-market trading. Ipsen and Exicure signed an exclusive collaboration agreement to research, develop, and... Via Benzinga NovaBay Pharmaceuticals Partners with Harrow Health’s ImprimisRx® to Promote Prescription Avenova July 19, 2021 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals to Participate in Two July Investment Conferences July 08, 2021 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Launches First of Several New Products to Expand Avenova Line May 17, 2021 From NovaBay Pharmaceuticals, Inc. Via Business Wire NovaBay Pharmaceuticals Reports First Quarter 2021 Financial Results May 06, 2021 From NovaBay Pharmaceuticals, Inc. Via Business Wire The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom May 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety NovaBay Pharmaceuticals to Hold First Quarter 2021 Conference Call on May 6 April 29, 2021 From NovaBay Pharmaceuticals, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.